Objective: This study sought to characterize changes in the angiopoietin system in a rat model of myocardial infarction (MI). Background: Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) bind to the endothelial-specific receptor tyrosine kinase, TIE-2. Ang-2 has been suggested to be an antagonist of TIE-2, possibly acting to release endothelial cells from the tonic stabilizing influence of Ang-1. However, on prolonged exposure, Ang-2 has been shown to acquire agonistic activity at TIE-2, raising the possibility that this isoform may play a direct role in neovascularization. Methods: Sprague -Dawley rats were subjected to left coronary ligation and myocardial tissues were harvested from the infarct and peri-infarct regions, or from non-infarcted myocardium. Changes in gene expression were determined by RT-PCR and confirmed by Northern analysis. Changes in protein expression were confirmed by Western analysis and immunocytochemistry, and TIE-2 activity was determined by immunoprecipitation with anti-TIE-2 and antiphosphotyrosine immunoblotting. Results: At 24 h, Ang-1 mRNA and protein expression within the infarct and peri-infarct regions were decreased compared to non-infarcted myocardium, whereas Ang-2 mRNA levels were markedly increased and TIE-2 expression was unchanged. Immunohistochemical staining revealed Ang-1 and TIE-2 immunoreactivity localized to vascular endothelium. In the infarct territory, Ang-2 immunostaining was localized primarily to invading leukocytes at 24 h. At 1 week, Ang-1 expression was partially restored, whereas Ang-2 expression remained elevated. At the time of peak elevation in Ang-2, Tie2 phosphorylation was found to be markedly increased, consistent with receptor activation. Conclusions: Thus, myocardial ischemia induced by left coronary artery ligation resulted in a sustained increase in Ang-2 expression and a reciprocal decrease in Ang-1, consistent with a predominant role for Ang-2 in the angiogenic response to MI.
Introduction
Angiopoietins represent a new family of angiogenic factors which bind the endothelial-selective receptor tyrosine kinase, TIE-2 [1] . Two principal angiopoietin isoforms have been identified, angiopoietin-1 (Ang-1), which activates TIE-2 and angiopoietin-2 (Ang-2), a putative endogenous TIE-2 receptor antagonist, thought to be a competitive inhibitor of the actions of Ang-1 [2] . Transgenic mice lacking either TIE-2 or Ang-1 exhibit embryonic lethality.
Morphological evaluation of TIE-2-or Ang-1-deficient mice have demonstrated diminished vessel branching, poorly organized subendothelial matrix, loosening of endothelial cell contacts and generalized lack of recruitment of pericytes [3, 4] . Transgenic overexpression of Ang-2 during embryogenesis also leads to a lethal phenotype similar to that seen in embryos lacking either Ang-1 or TIE-2 [2] , consistent with an antagonistic action of Ang-2 in vivo. These data support a role for Ang-1/TIE-2 interactions in the expansion of the primitive vascular plexus into a hierarchical network of mature vessels composed of endothelial and medial smooth muscle cells and/or pericytes. Indeed, the angiopoietins appear to act in a complementary and coordinated fashion with VEGF, increasing the complexity and maturity of the neovasculature [5] .
The angiopoietins also appear to play an important role in postnatal neovascularization. In the adult, Ang-1 and TIE-2 appear to be widely expressed in the quiescent vasculature, whereas Ang-2 is expressed only at sites of vascular remodeling [2] . In vitro studies have shown that hypoxia upregulates Ang-2 expression [6, 7] and downregulates Ang-1 [8] . In a corneal micro-pocket model of angiogenesis, Asahara et al [9] showed that exogenous coadministration of Ang-1 with VEGF produced more numerous blood vessels than VEGF alone, whereas Ang-2 increased the length but not density of neovessels. In a rabbit hindlimb model of ischemia, direct intramuscular injection of Ang-1 plasmid DNA augmented collateral formation [10] .
However, to date the effects of ischemia on Ang-1, Ang-2 or the TIE-2 receptor expression in vivo have not been defined. Detailed characterization of the spatial and temporal changes in endogenous Ang-1, Ang-2 and TIE-2 expression induced by myocardial ischemia is essential for the elucidation of the role of this new family of angiogenic mediators in coronary collateral vessel formation. In this study, we have looked at the changes in the angiopoietin system in the rat heart induced by permanent coronary artery occlusion. We now report that myocardial infarction (MI) was associated with a substantial increase in Ang-2 expression which was sustained for at least 1 week, whereas Ang-1 expression was decreased. These results suggest that the endogenous angiopoietin system, in particular Ang-2, may play an important role in neovascularization following MI and ischemia.
Methods
This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and with the Canadian Council of Animal Care guidelines under a protocol approved by the Institutional Animal Care and Use Committee Guidelines at St. Michael's Hospital.
Experimental preparation
Male Sprague -Dawley rats (250 -450 g) were anesthetized with a combination of ketamine (120 mg/kg) and xylazine (17 mg/kg) administered intraperitoneally, and ventilated with room air (Harvard Apparatus). The left main coronary artery was ligated near its origin using a 6.0 proline suture. Animals were subjected to permanent coronary artery occlusion for 24 h, 1 week or 6 weeks. Rats subjected to transient ischemia received 5 min of temporary coronary artery occlusion followed by 24 h of reperfusion by slipping a section of blunt ended PE190 tubing over the two loose ends of the suture to form a snare and clamping it tightly for 5 min against the myocardium. The presence of occlusion was confirmed by observing epicardial cyanosis in the area subserved by the occluded artery [11] . After the appropriate time-points the rats were re-anesthetized using ketamine/ xylazine, and the hearts were rapidly excised and rinsed in room-temperature saline. The atria and right ventricular free wall were dissected free of the left ventricle (LV). The LV ventricle was divided into three regions: (1) infarct zone, (2) peri-infarct zone consisting of normal appearing myocardium surrounding the infarct zone, and (3) normal zone distant from the infarct and peri-infarct zones. The infarct zone could be readily distinguished from the normal myocardium surrounding it by its distinctive pale coloration. In the shamoperated and normal control animals, the entire left ventricle was quick-frozen. For immunohistochemistry, rats were sacrificed with 1.2 ml of T-61. The hearts were pressurefixed in situ with 3% paraformaldehyde in phosphate buffered saline at 100 mm Hg.
Cells culture
Human THP-1 monocyte and human umbilical cord endothelial cell (HUVEC) were obtained from American Type Culture Collection (ATCC). HUVEC were grown in Kaighn's F12K medium containing endothelial cell growth factor (ECGF, Roche) and 10% fetal bovine serum. THP-1 monocytes were cultured in RPMI medium according to ATCC recommendations, and were differentiated to macrophages in the presence of phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA, 162 nM), as described previously [12] . Confluent cultures of monocytes, macrophages and ECs were incubated in a humidified atmosphere of 5% CO 2 in air at 37 jC (normoxia). For comparison, HUVEC were exposed to hypoxia (95%N 2 /5%CO 2 ) for 24 h. Ang-1 and Ang-2 mRNA expression was determined by real-time quantitative RT-PCR.
Semi-quantitative (RT-PCR)
Total RNA was isolated using Trizol Reagents (Invitrogen) and 6 Ag of total RNA was reverse transcribed in 60 Al volumes using Moloney murine leukemia virus (MMLV) reverse transcriptase (Invitrogen) with 1 Ag random primers (Invitrogen). For each RT product, aliquots (2-10 Al) of the final reaction volume were amplified in four parallel PCR reactions using Ang-1,-Ang-2-, TIE-2-, or GAPDH-specific primers and Taq polymerase (Pharmacia Biotech Amersham). Partially degenerate oligonucleotides were used for Ang-2, as described previously [6] . The following primers were used: Ang-1 forward: 5V-CACGACAGACCAGTACAACA-CAAACG-3V, reverse: 5V-GACGACTGTTGTTGGTGG-TAGCTCT-3V; Ang-2 forward: 5V-GT(T/G)GA(T/C)TT(T/ C)CAGAG(A/G/T/C)AC(A/G/T/C)CC(T/C)TTCCA-3V, reverse: 5V-CGA(A/G)TAGCC(T/G)GA(A/G/T/C)CC(T/C) TTCCA-3V; TIE-2 forward: 5V-CAGGACCTTCACAA-CAGCTTCTATCGGACT-3V, reverse: 5V-CTGTCGAA-GAATGTCACTAAGGGTCCAAGC-3V; GAPDH forward: 5V-CTCTAAGGCTGTGGGCAAGGTCAT-3V, reverse: 5V-GAGATCCACCACCCTGTTGCTGTA-3V.
The expected size of PCR products for Ang-1, Ang-2, TIE-2, and GAPDH were 570, 450, 322, and 343 bp, respectively. Quantification of RT-PCR products was done by ethidium bromide staining and densitometry. Results were evaluated as the ratio between the target genes and GAPDH. For the permanent occlusion experiments, five to seven animals were used for each time-point.
Real-time quantitative RT-PCR
Reverse transcription (RT) was carried out with 0.5 Ag of total RNA using Omniscript reverse transcriptase according to the manufacturer's instruction (Qiagen). One microliter of each RTs was added to the real-time PCR amplification mixture (final volume, 30 Al) containing 15 Al of 2 Â SYBR Green I Master Mix buffer (Applied Biosystems) and 0.5 AM forward and reverse primer. The following primers were used: VEGF165 forward: 5V-CAT-AGGAGAGATGAGCTTCCTGC-3V, reverse: 5V-AACAA GGCTCACAGTGATTTTCTG-3V; Ang-1 forward: 5V-GCC ACTTGAGAATTACATTGTGG-3V, reverse: 5V-CGCGGA TTTTATGCTCTAATCAACTG-3V; Ang-2 forward: 5V-GT CTCCCAGCTGACCAGTGGG-3V, reverse: 5V-TACC ACTTGATACCGTTGAAC-3V. GAPDH was amplified in parallel with the genes of interest using primers from Applied Biosystems. Reactions were run on an ABI PRISM 7900HT Sequence Detector (Applied Biosystems, Foster City, CA). The cycling conditions were as follows: 95 jC, 10 min (1 Â) [95 jC, 15 s, 60 jC, 60 s] (40 Â). Following the amplification, a dissociation curve was generated by increasing the temperature from 50 to 95 jC at a maximum ramp setting of 0.25 jC/min to ensure only a single product was amplified. Data were analyzed using SDS 2.1 (Applied Biosystems) to obtain the threshold cycle (Ct) values. Results were calculated as the expression difference between samples comparing the peri-infarct or infarct myocardium to the normal LV, normalized to the gene of reference (GAPDH). We used the 2 T ÀDDC method to determine the relative gene expression between groups, as described by Livak and Schmittgen [13] .
Northern blotting
Ten micrograms of total RNA was electrophoresed on 1.1% formaldehyde-agarose gel and then transferred to a nylon membrane (Hybond-N, Amersham Pharmacia Biotech), covalently linked, using a UV cross-linker system (Stratagene, La Jolla, CA) and then hybridized with Ang-1, Ang-2, TIE-2, and GAPDH probes. A 800-bp HindIII/XbaI restriction enzyme fragment, excised from a pFLAG-CMV-1 expression vector containing the full length of human Ang-1 (kindly provided by Dr. G.Y. Koh, Woosuk University, Chonju, South Korea), was used as an Ang-1 probe. The Ang-2 and TIE-2 probes were generated by RT-PCR, with primers described above. GAPDH cDNA was obtained from Ambion (Austin, TX USA). cDNA probes were labeled to a specific activity of at least 1 Â 10 9 cpm/Ag with a-[
32 P]dCTP (Amersham) by the random decamer (10-mer) primer extension-labeling standard technique (DECAprime II DNA labeling kit, Ambion). Northern blotting was performed as previously described [14] .
Immunoblotting
Frozen tissue samples were homogenized in RIPA lysis buffer according to standard procedures (Santa Cruz Biotechnology, Santa Cruz, CA). Total protein (150 Ag) was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) in 4-20% Tris -glycine gels (Invitrogen), subsequently transferred to nitrocellulose membranes and blocked in 5% non-fat milk in TBST buffer (10 mM/l Tris 150 mM/l NaCl, pH 7.5) and 0.1% Tween 20. The membranes were then incubated overnight with goat antirat polyclonal antibodies to Ang-1 or Ang-2 (Santa Cruz Biotechnology) at a dilution of 1:200, in TBS with 2% skim milk, followed by an anti-goat IgG secondary antibody conjugated to horseradish peroxidase (1:2000, 1 h; Santa Cruz Biotechnology). Angiopoietin-specific bands (70 kDa) were visualized using an enhanced chemiluminescence substrate system ECL (Amersham Pharmacia Biotech). Densitometry was performed and the intensity of each band was analyzed using the Molecular Analyst software (Imaging Densitometer, Bio-Rad). Six animals were studied in each group.
TIE-2 receptor phosphorylation
Tissue samples were homogenized in RIPA buffer and 500 Ag of total protein from each tissue lysate were immunoprecipitated with a TIE-2 polyclonal antibody (Santa Cruz Biotechnology) as previously described [15] . The membranes were probed with a TIE-2 monoclonal antibody (clone Ab33, Upstate Biotechnology; 0.5 Ag/ml) for total TIE-2 signal and then with an anti-phosphotyrosine antibody (4G10, Upstate Biotechnology; 1:3000) for receptor phosphorylation state as described [15] . Bands were visualized using the ECL system and densitometric analysis was performed as described above. This experiment was performed in triplicate.
Immunohistochemistry
Transverse slabs of the heart containing the infarcted area were processed for paraffin sectioning using standard techniques. Sections (6 Am) were stained with hematoxylin and eosin for histological analysis and adjacent sections were used for immunohistochemistry. The indirect streptavidin -biotin peroxidase method was used and paraffin sections were pretreated with 0.5% pepsin for 30 min at 37 jC prior to overnight incubation in primary antibody at 4 jC. Dilutions of antibodies (Santa Cruz Biotechnology) were as follows: goat anti-Ang-1 and Ang-2, 1:100; and rabbit anti-TIE-2, 1:550. The controls for immunohistochemistry included: (1) omission of the primary antibody, and (2) use of non-immune serum in place of the primary antibody. Immunohistochemistry was not performed for the 6-week time-point as there were no changes in either RNA or protein expression for any of the genes studied.
Double labeling for Ang-1 and Ang-2 was also done using link antibodies conjugated with fluorochrome dyes. Sections were first reacted with antibody to Ang-2 overnight at 4 jC and then with a biotinylated link antibody followed by streptavidin-Cyk3 (Jackson Immunoresearch Laboratories, Westgrove, PA). Hence the presence of Ang-2 was detected by red fluorescence. Sections were then blocked with normal rabbit serum and incubated for 2 h with Ang-1 antibody at room temperature followed by rabbit anti-goatAlexa Fluork488 antibody (Molecular Probes, Eugene, OR). Hence Ang-1 was detected by green fluorescence. These sections were analyzed using a Nikon Optiphot microscope and a MRC 600 confocal laser scanning microscope (Bio-Rad). Images were merged using Adobe Photoshop 6.0 software. Co-localization of Ang-1 and Ang-2 was indicated by yellow fluorescence.
Statistical analysis
Comparison of levels of expression and phosphorylation in the infarct and peri-infarct regions to that in the normal myocardium of the same heart was performed by paired t-tests. For all other comparisons, a one-way ANOVA with post hoc Tukey's HSD test (also known as Tukey's A) was used. p < 0.05 was accepted as statistically significant.
Results

Myocardial ischemia model
Fifty-one animals surviving the initial perioperative period following permanent left coronary artery occlusion were entered into the study. Of these, 44 animals survived to the predetermined end-study (85%), 39 of which exhibited clear evidence of myocardial infarction and were subsequently used for further analysis. Of the five rats subjected to transient ischemia, all exhibited clear cyanosis during the period of occlusion. In addition, nine animals were sacrificed without prior surgery and served as normal controls. Six additional animals were subjected to thoracotomy with placement of a suture in the myocardium without coronary artery ligation and served as sham-operated controls. In rats subjected to permanent coronary artery occlusion, infarct size was measured in histological sections in a subset of hearts at 1 day, 3 days and 1 week, and showed variation in size ranging from 15% to 60% of the left ventricle with an average size of approximately 40% of the left ventricle.
3.2. Alterations in angiopoietin -TIE-2 system after permanent coronary artery occlusion
RT-PCR
Twenty-four hours after MI, Ang-1 mRNA levels were consistently reduced in the infarct and peri-infarct zones (Fig. 1) to 46 F 11% and 87 F 6% of non-infarcted LV, respectively ( p < 0.005). At the same time, Ang-2 levels were increased in both the infarct and peri-infarct zones (241 F 71% and 222 F 63% of non-infarcted LV, respectively, p < 0.05). There were no significant changes in TIE-2 expression in either the infarct or peri-infarct zone at this time-point. No differences in expression of Ang-1 and Ang-2 were found in different regions of the LV from shamoperated animals (data not shown).
The decrease in Ang-1 and the increase in Ang-2 persisted for at least 1 week after coronary artery ligation in the infarct zone, whereas, in the peri-infarct zone, levels of both Ang-1 and Ang-2 had returned to baseline values by 1 week. TIE-2 mRNA levels in the infarct zone remained unchanged at 1 week (137 F 22%, p = 0.16).
At 6 weeks post-infarction, mean values for Ang-1, Ang-2, and TIE-2 levels were not significantly different from those in the non-infarcted myocardium (data not shown). As well, there were no significant differences in Ang-1, Ang-2, or TIE-2 levels at any time-point measured either in noninfarcted myocardium from MI animals or normal myocardium from sham-operated or normal rats. Representative Northern blots and summary data for the densitometric analysis at 24 h post MI are presented in Fig. 2 . The findings from Northern analysis were similar to the RT-PCR findings.
Immunohistochemistry
Control rats showed selective endothelial immunostaining for Ang-1 in all cardiac vessels by both immunocytochemistry (Fig. 3A) and immunofluorescence (Fig. 4A) , whereas there was no immunoreactivity with the Ang-2 antibody (Fig. 3B) . As well, Ang-1 immunostaining was not observed when non-immune serum was substituted for primary antibody. Rats subjected to 24 h of coronary artery occlusion showed marked reduction in endothelial Ang-1 immunoreactivity in vessels in the infarct zone (Fig. 3C) . However, polymorphonuclear leukocytes present in the infarcted region stained strongly for both Ang-1 and Ang-2, the latter showing more consistent and homogeneous pattern of immunostaining (Fig. 3C,D) . Merged confocal images showed co-localization of Ang-1 and Ang-2 in the polymorphonuclear leukocytes (Fig. 4B) . As well, a few vessels in the peri-infarct zone showed endothelial Ang-2 immunoreactivity (Table 1) . In contrast, vessels of all sizes distant from the infarct zone showed strong endothelial Ang-1 immunoreactivity, similar to those of controls and were non-reactive for Ang-2 (Table 1) . Ang-1 and Ang-2 immunoreactivity persisted in fewer inflammatory cells present within the lesion at 3 days. As well, Ang-1 immunoreactivity was seen in occasional necrotic myofibres, and neovessels within the infarct and the surrounding regions (Table 1) . At this time, an increasing number of vessels within the infarct showed endothelial Ang-2 immunoreactivity as compared with the 24-h time period. At 1 week, most vessels within the infarct, including the neovessels, showed definite endothelial Ang-1 immunoreactivity (Fig.  3E ). Neovessels were identified as clusters of vessels at the margin of the infarct having varying lumen diameters and wall thickness, as shown well in Figs. 3E,F and 4C,D. Merged confocal images showed endothelial co-localization of Ang-1 and Ang-2 both in vessels within the infarct as well as in neovessels (Fig. 4C,D) . The early decreases in ) showing Ang-1, Ang-2, and TIE-2 mRNA expression in normal myocardium from shamoperated rats, compared to samples taken from non-infarcted myocardium (NI) and from within the peri-infarct (PI) and infarct (I) zones at 24 h after permanent coronary artery occlusion. Summary data for Ang-1, Ang-2, and TIE-2 expression at 24 h after permanent coronary artery occlusion is shown in panel B (n = 3 -5 for each group). Expression of each gene is normalized to the GAPDH signal in the same sample. Data are shown as mean F S.E.M. *p < 0.05 compared to normal myocardium. Ang-1 and increases in Ang-2 protein expression in the infarct and peri-infarct zones were confirmed by Western blot analysis (Fig. 5) .
Angiopoietin expression in inflammatory cells
To further explore the role of inflammatory cells in the de novo production of angiopoietins post myocardial infarction, we exposed THP-1 monocytes to TPA for 48 h. In the monocyte cell line, basal levels of both angiopoietins were very low; however, when THP-1 cells were activated by TPA to undergo differentiation into adherent macrophagelike cells, there was a 2.7-fold increase in Ang-1 ( p = 0.07, n = 4) and a 6.95-fold increase in Ang-2 mRNA expression ( p = 0.03, n = 4). Furthermore, in HUVEC exposed to hypoxia, Ang-2 levels increased while Ang-1 levels decreased (data not shown) in agreement with previously reported findings [6, 8] .
TIE-2 receptor autophosphorylation post MI
The phosphorylation state of TIE-2 was determined at 24 h, a time period at which the greatest changes in Ang-1 and Ang-2 expression were observed. As shown in Fig.  6A , there was only a modest phosphotyrosine signal in the non-infarcted myocardium. However, in the infarct and peri-infarct regions there was a profound increase in TIE-2 phophorylation reaching levels >10-fold baseline. As shown in Fig. 6B , there was a strong relationship between increases in Ang-2 protein expression and increased TIE-2 phosphorylation, with an R 2 value approaching unity.
Relationship between the expression profiles of VEGF and Ang-2
To obtain a quantitative measure of VEGF expression relative to Ang-1 and Ang-2 in our model, we used quantitative real-time RT-PCR. The time course of changes in the expression of VEGF and its receptors has previously been described in detail [16] . In agreement with the previous report, VEGF mRNA levels were significantly increased in both the infarct and peri-infarct zones 24 h after MI (Fig. 7) , correlating with elevated Ang-2 mRNA. However, if anything the magnitude of increase in Ang-2 was greater than that for VEGF. As before, Ang-1 mRNA levels were consistently reduced in the infarct and peri-infarct zones. Infarct  0  1  3  0  1  2  Peri-infarct  Intrinsic vessels  3  3  4  1  2  3  Neovessels  0  1  3  0  2  3  Normal LV  4 Results from real-time RT-PCR also confirmed data previously obtained by semi-quantitative RT-PCR for Ang-1 and Ang-2 expression patterns ( Figs. 1 and 2 ).
Alterations the angiopoietin -TIE-2 system after transient coronary artery occlusion
After 5 min of transient coronary artery occlusion followed by 24 h reperfusion, Ang-1 mRNA expression was modestly, but significantly, decreased in the ischemic zone (84 F 3% of normal LV, p = 0.05). Ang-2 and TIE-2 levels were not significantly altered in either the ischemic or periischemic zone (Fig. 8) .
Discussion
The present report describes changes in the spatial and temporal patterns of Ang-1, Ang-2, and TIE-2 expression in response to myocardial ischemia and infarction. In the rats subjected to permanent coronary artery occlusion, Ang-2 expression was increased in the infarct and peri-infarct regions of myocardium relative to the non-infarcted myocardium. The greatest increases in Ang-2 were observed , and total TIE-2. In panel B, the fold-increase in pTIE-2 is plotted against the increase in Ang-2 protein expression in both the peri-infarct and infarct regions for three separate animals. Fig. 7 . Changes in VEGF, Ang-1, and Ang-2 mRNA expression as detected by real-time PCR in the rat myocardium 24 h after permanent coronary artery occlusion. Results were calculated as the fold expression difference between infarct or peri-infarct comparing to non-infarcted (normal) LV when normalized to GAPDH signal of the same sample using mathematical 2 T À DDC model [13] . Each bar represents mean data from three rats F S.D. * indicates p < 0.05 as compared to the normal myocardium in the same heart. 24 h after MI, prior to the onset of neovascularization in this model, and persisted for up to 1 week, a time period during which neovascularization was prominent [17 -19] . The profound increase in myocardial Ang-2 expression was localized mainly to the periphery of the infarct and associated with invading leukocytes, which also exhibited heterogeneous expression of Ang-1. To our knowledge, this is the first report of angiopoietin expression by inflammatory cells in the heart; however, Ang-2 immunostaining has been demonstrated in alveolar macrophages in a mouse acute lung injury model [20] . The mechanism of induction of angiopoietin expression by leukocytes post MI is not yet known. Hypoxia and cytokines, including VEGF, basic fibroblast growth factor (bFGF) and tumour necrosis factor-a (TNF-a) [6, 7] , have been shown to upregulate endothelial Ang-2 expression in various cell types. Indeed, activation of THP-1 monocytes with TPA in vitro markedly increased the expression of Ang-2, and less so, Ang-1, consisting with the pattern of expression observed in inflammatory cells within the infarct zone (Fig. 3) . Previous studies have demonstrated that the activated leukocytes produce a number of different angiogenic peptides such as IL-8 [21] , Gro-a [22] , TNF-a [23] , transforming growth factor-h (TGF-h) [24] , as well as VEGF [21, 25] . These cytokines appear to be involved in the classic acute phase response to injury, which may be critical for tissue repair and healing.
Ang-2 expression was also evident in endothelial cells at the forefront of vessels invading the infarct zone, a pattern similar to that seen in highly angiogenic glioblastomas [26] . In the ovary, high levels of both Ang-2 and VEGF were observed during growth and neovascularization of the follicle, whereas Ang-2 expression alone was associated with involution of the follicle and vascular regression [2] . This pattern of expression has led to the suggestion that Ang-2 may act in concert with VEGF as a permissive factor in the earliest stages of angiogenesis by releasing endothelial cells from the inhibitory actions of Ang-1 [2, 27] . However, increased Ang-2 (and decreased Ang-1) expression in the rat MI model persisted for more than 1 week after the onset of ischemia, too long to be involved solely in the initiation of the angiogenic response. As well, since Ang-1 has been shown to potentiate angiogenesis in response to VEGF in vivo [9] , the continued expression of a TIE-2 antagonist would seem to be counter-productive to efficient neovascularization.
In the present study, the activation state of TIE-2 was determined by immunoprecipitation and phosphotyrosine immunoblotting at a time-point corresponding to the maximal decreases in Ang-1 and increases in Ang-2 expression. Rather than a decreased level of Tie2 activity, there was marked activation of TIE-2 which was highly correlated with the increase in Ang-2 expression. Interestingly, at least two groups have recently reported that Ang-2 may promote angiogenesis in vitro and increase endothelial cells survival [15, 28] through the direct activation of endothelial TIE-2 in certain conditions, including during prolonged exposure [15] or at high concentrations [28] . Thus, Ang-2 may have dual activities in myocardial ischemia [29] , initially blocking the effect of Ang-1 by acting as a TIE-2 antagonist, enhancing EC activation in response to VEGF, and then later contributing to the stabilization and maturation of newly formed neovessels as a context-dependent agonist of the TIE-2 receptor. To our knowledge, this is the first demonstration of activation of TIE-2 associated with a selective increase in Ang-2 expression in vivo.
In contrast to Ang-2, Ang-1 was downregulated throughout the period of neovascularization of the healing infarct. This is in agreement with a previous report describing prolonged reduction in Ang-1 expression following MI in the rat using a cDNA micro-array approach [30] . Hypoxia has also been reported to downregulate Ang-1 in rat glioma cells in vitro [8] ; however, systemic hypoxemic hypoxia in the rat has been shown either to increase [31] or decrease [32] Ang-1 expression, whereas Ang-2 was transiently increased [31] . Ang-1 production was also downregulated by a number of angiogenic growth factors, including epidermal growth factor (EGF), transforming growth factor (TGF-h), and platelet-derived growth factor (PDGF) [8] . In the current study, we also observed a significant decrease in Ang-1 expression after transient ischemia and reperfusion. Coronary artery occlusion of 5 min or less has been shown previously to increase expression of bFGF and VEGF [33] . Capillary density can also be increased by such short episodes of transient ischemia, persisting for up to 1 month after the acute ischemic event [33] . The period of transient ischemia used in the current study was not associated with infarction in this model [33] , and therefore, this permits the examination of the effects of ischemia on the angiopoietin -TIE-2 system, independent from any changes that occur secondary to myocardial infarction. This investigation represents the first comprehensive analysis of the alterations in expression and tissue distribution of the angiopoietin system in a relevant model of myocardial ischemia and infarction. Our results indicate that there are profound and sustained changes in Ang-1 and Ang-2 gene expression, and provide a basis for a more complete understanding of the potential role of this novel angiogenic system in neovascularization and tissue repair following MI. In particular, they suggest a critical role for Ang-2 in the angiogenic response to myocardial infarction, and support further research into the complex interactions between Ang-1 and Ang-2 at the TIE-2 receptor, and into their functional relevance in vivo.
